Shane Ryan
Chief Executive Officer
Shane Ryan, previously Global SVP of Strategy & Innovation – Patient Access at GenesisCare, brings over 20 years of expertise in global oncology, focusing on breast cancer. Renowned for his extensive oncology network, Mr Ryan excels in patient care, research, and pioneering service models. His impactful contributions span precision medicine tests and clinical trials, particularly for high-risk breast cancer. Prior to his role at GenesisCare, he held executive positions at Peter MacCallum Cancer Centre for a decade.
Meet the rest of the team
BCAL is led by a team of experts with deep experience in biotechnology, diagnostics, and healthcare innovation. Our leadership is dedicated to advancing scientific excellence and bringing practical, life-changing solutions to women worldwide.
Shane Ryan
Chief Executive Officer
Kathy Koskiris
Director of Clinical Laboratory Services
Guy Robertson
Chief Financial Officer & Company Secretary
Dr Simon Preston
Director Clinical Research
Alexandra Feetham
Head of Innovation
Kim Kirkham
National Clinical Program Director
Dr Mark David
Director Discovery of Product Development. Senior Clinical Scientist
Dr Chris Baldwin
Chief Commercial Officer
Dr Klaus-Peter Adam
Director of US Research & Product